Jupiter Neurosciences, Inc.

Contributing Author

Recent Articles by Jupiter Neurosciences, Inc.

Jan-28	Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users JUNS -23.53% GlobeNewswire
Dec-23	Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 JUNS GlobeNewswire
Dec-03	Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum JUNS GlobeNewswire
Nov-05	Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson's Disease JUNS +8.80% GlobeNewswire
Oct-27	Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing JUNS +11.11% GlobeNewswire
Sep-15	Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia Brand Ambassador JUNS +5.26% GlobeNewswire
Aug-26	Jupiter Neurosciences Launches Nugevia Website and Opens Pre-Orders for Groundbreaking Longevity Supplements JUNS GlobeNewswire
Aug-19	Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia Brand Ambassador JUNS GlobeNewswire
Aug-11	Jupiter Neurosciences Introduces Nugevia MND: A Cognitive Health Supplement Leveraging Clinically Validated Neuroscience JUNS GlobeNewswire
Jul-23	Jupiter Neurosciences Highlights Critical Advancement of JOTROL Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science JUNS GlobeNewswire
Jul-10	Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement JUNS +19.90% JUNS +18.63% GlobeNewswire
Jun-30	Jupiter Neurosciences Showcases Nugevia PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery JUNS GlobeNewswire
Jun-27	Jupiter Neurosciences Unveils Nugevia GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science JUNS GlobeNewswire
Jun-23	Jupiter Neurosciences Names Golf Legend Annika Sorenstam as First Nugevia Brand Ambassador JUNS +8.11% GlobeNewswire
Jun-09	Jupiter Neurosciences Launches Nugevia: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science JUNS +15.20% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.